On Tuesday, December 12th, it will be our pleasure to welcome Dr. Yves Durocher at the AFSB research centre as a speaker for the Pierre Talbot conferences of the INRS Infectiopôle. Dr. Durocher is an associate professor at the University of Montreal, as well as a research officer for the National Research Council of Canada, which he joined in 1995 after obtaining his doctorate from the University of Montreal. Dr. Durocher also has the title of Section head of mammalian cell expression at the Human Health Therapeutics Research Centre of the NRC, where he leads a team of 33 members.
Thanks to his multiple years of experience, Dr. Yves Durocher has an unparalleled expertise regarding protein expression and CHO (Chinese Hamster Ovary) cell line manufacturing, which he applies towards various internal projects at his research centre as well as for external clients, such as various SMBs (small and medium size businesses) that seek the help of the Human Health Therapeutics Research Centre of the NRC. As an example, his most recent publication explores the possibility of using CHO cell lines in order to produce VLP (virus-like particles) that express the spike antigen of SARS-CoV-2, a technology that could allow the production of new vaccines against COVID-19.
Thus, on December 12th, at 11 A.M, Dr. Durocher will give a presentation titled “Stable CHO pools to accelerate biologics manufacturing for clinical trials” in the “Salle Pasteur” of the AFSB Centre, which should offer insights in the manufacturing process of stable CHO cell lines and their modification. Be sure to mark your calendars, and dont miss this opportunity to learn from one of the leading figures in the field.